Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer
Angelika M Burger1, Brian Leyland-Jones, Kris Banerjee
1Laboratory of Molecular Pathology, Department of Anatomic Pathology and Division of Molecular and Cellular Biology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ont., Canada. angelikaburger@aol.com
Abstract:
Insulin and insulin-like growth factors (IGFs) have critical functions in growth regulatory signalling pathways. They are part of a tightly controlled network of ligands, receptors, binding proteins and their proteases. However, the system becomes uncontrolled in neoplasia. The insulin-like growth factor binding protein 3 (IGFBP-3) and the insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) have unique properties among the sixteen known members of the IGFBP superfamily. IGFBP-3 has very high affinity for IGFs (k(d) approximately 10(-10) M), it transports >75% of serum IGF-I and -II, whereas it's affinity for insulin is very low. On the other hand, IGFBP-rP1 binds insulin with very high affinity (500-fold higher compared to other IGFBPs), but has low affinity for IGF-I and -II proteins (k(d) = 3 x 10(-8) M). In this review, we have examined the roles of IGFBP-3 and IGFBP-rP1 in breast cancer, and discuss the potential impact of these two proteins in mammary carcinoma risk assessment and the development of treatments for breast cancer.
Insights
Insulin-like growth factor binding proteins (IGFBPs), specifically IGFBP-3 and IGFBP-rP1, play distinct roles in breast cancer. Their unique binding affinities for IGFs and insulin suggest potential in cancer risk assessment and treatment development.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Insulin and insulin-like growth factors (IGFs) are crucial for growth regulation but become dysregulated in cancer.
- The insulin-like growth factor binding protein (IGFBP) superfamily comprises 16 members with diverse functions.
- IGFBP-3 and IGFBP-rP1 exhibit unique ligand-binding properties within this superfamily.
Purpose of the Study:
- To review the roles of IGFBP-3 and IGFBP-rP1 in breast cancer.
- To explore the potential of these proteins in assessing breast cancer risk.
- To discuss their implications for developing novel breast cancer therapies.
Main Methods:
- Literature review of studies on IGFBP-3 and IGFBP-rP1 in breast cancer.
- Analysis of ligand-binding affinities and biological functions.
- Synthesis of information regarding their involvement in mammary carcinoma.
Main Results:
- IGFBP-3 binds IGFs with high affinity, transporting most serum IGFs, and has low affinity for insulin.
- IGFBP-rP1 binds insulin with high affinity, distinguishing it from other IGFBPs, while having low affinity for IGFs.
- Both proteins are implicated in the complex signaling pathways of breast cancer.
Conclusions:
- IGFBP-3 and IGFBP-rP1 possess distinct molecular characteristics relevant to breast cancer.
- Their unique binding profiles offer potential as biomarkers for breast cancer risk stratification.
- Targeting IGFBP-3 and IGFBP-rP1 may represent a promising therapeutic strategy for breast cancer treatment.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Negative Regulator Molecules
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of the Unfolded Protein Response
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
